Asset Management One Co. Ltd. Invests $421,000 in Encompass Health Co. (NYSE:EHC)

Asset Management One Co. Ltd. acquired a new position in shares of Encompass Health Co. (NYSE:EHC) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 6,261 shares of the company’s stock, valued at approximately $421,000.

A number of other hedge funds have also modified their holdings of EHC. Baupost Group LLC MA increased its stake in shares of Encompass Health by 318.9% during the 1st quarter. Baupost Group LLC MA now owns 3,000,000 shares of the company’s stock worth $213,330,000 after purchasing an additional 2,283,900 shares in the last quarter. Norges Bank purchased a new position in shares of Encompass Health during the 4th quarter worth approximately $58,988,000. Invesco Ltd. boosted its position in Encompass Health by 22.3% during the third quarter. Invesco Ltd. now owns 3,974,306 shares of the company’s stock worth $266,914,000 after acquiring an additional 724,544 shares during the last quarter. Holocene Advisors LP boosted its position in Encompass Health by 3,070.3% during the second quarter. Holocene Advisors LP now owns 574,171 shares of the company’s stock worth $38,877,000 after acquiring an additional 556,060 shares during the last quarter. Finally, Millennium Management LLC boosted its position in Encompass Health by 83.4% during the fourth quarter. Millennium Management LLC now owns 980,352 shares of the company’s stock worth $58,635,000 after acquiring an additional 445,741 shares during the last quarter. 97.25% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of brokerages recently issued reports on EHC. Royal Bank of Canada restated an “outperform” rating and set a $83.00 target price on shares of Encompass Health in a research report on Friday, February 9th. Truist Financial raised their target price on shares of Encompass Health from $82.00 to $86.00 and gave the stock a “buy” rating in a research report on Friday, February 9th. Barclays raised their target price on shares of Encompass Health from $95.00 to $101.00 and gave the stock an “overweight” rating in a research report on Thursday, March 28th. Stephens reiterated an “overweight” rating and issued a $85.00 price target on shares of Encompass Health in a report on Tuesday, January 16th. Finally, Mizuho lifted their price target on shares of Encompass Health from $77.00 to $82.00 and gave the company a “buy” rating in a report on Friday, February 9th. Eight equities research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Buy” and an average price target of $83.22.

Encompass Health Stock Performance

NYSE:EHC opened at $80.49 on Friday. The company has a current ratio of 1.28, a quick ratio of 1.28 and a debt-to-equity ratio of 1.19. The firm has a market capitalization of $8.06 billion, a price-to-earnings ratio of 23.20, a PEG ratio of 1.51 and a beta of 0.94. The firm’s fifty day simple moving average is $76.68 and its 200 day simple moving average is $69.89. Encompass Health Co. has a twelve month low of $57.55 and a twelve month high of $83.73.

Encompass Health (NYSE:EHC) last posted its earnings results on Wednesday, February 7th. The company reported $0.95 earnings per share for the quarter, beating the consensus estimate of $0.83 by $0.12. The business had revenue of $1.25 billion for the quarter, compared to analyst estimates of $1.24 billion. Encompass Health had a net margin of 7.33% and a return on equity of 17.69%. As a group, equities research analysts expect that Encompass Health Co. will post 3.96 earnings per share for the current fiscal year.

Encompass Health Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Monday, April 15th. Investors of record on Monday, April 1st will be issued a dividend of $0.15 per share. The ex-dividend date of this dividend is Thursday, March 28th. This represents a $0.60 annualized dividend and a dividend yield of 0.75%. Encompass Health’s payout ratio is 17.29%.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.